Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Asano

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Cancers|November 27, 2025
Factors Associated with Bone Union Failure After Frozen Autograft Reconstruction in Lower Limb OsteosarcomaSei Morinaga, Katsuhiro Hayashi, Shinji Miwa, et al.
Anticancer Research|June 26, 2024
Membrane Formed Around Liquid Nitrogen-treated Bone Promotes Osteogenesis and Revitalization in a Rat ModelYohei Asano, Norio Yamamoto, Katsuhiro Hayashi, et al.
Cancer Diagnosis & Prognosis|July 2, 2026
Pediatric Distal Femoral Surface Tumor With Extraosseous Lesion Mimicking Parosteal Osteosarcoma: A Diagnostic ChallengeRio Wikanjaya, Sei Morinaga, Katsuhiro Hayashi, et al.
Anticancer Research|June 27, 2025
The Conditions of Non-rescuability of Methioninase-treated Cancer Cells by Methionine Replenishment: The Point of No ReturnByung Mo Kang, Qinghong Han, Shukuan Li, et al.
The Journal of Hand Surgery Asian-Pacific Volume|April 22, 2020
Timing of Surgery for Pediatric Supracondylar Humerus Fractures and Early Postoperative ResultsSeigo Suganuma, Kaoru Tada, Hidetoshi Yasutake, et al.
Cancer Diagnosis & Prognosis|May 4, 2026
The Combination of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 and Recombinant Methioninase Is Not Cancer-selective in a Co-culture Model of Colon Cancer Cells and Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Journal of Medical Case Reports|November 16, 2022
Insufficiency fracture of the supra-acetabulum that required differentiation from a pathological fracture secondary to a malignant bone tumor: a case reportSei Morinaga, Norio Yamamoto, Katsuhiro Hayashi, et al.
Anticancer Research|November 29, 2025
The Combination of Recombinant Methioninase and Low-dose Chloroquine Selectively Eradicates Colon-Cancer Cells Without Apparent Toxicity on Co-cultured Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research|December 30, 2025
Effect of Recombinant Methioninase Dose and Timing on the Selective and Precise Elimination of Cancer Cells from Co-Cultured Normal Cells and on Methionine-dependent Rescue of Cancer CellsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research|October 28, 2025
Simultaneous Targeting of Multiple Hallmarks of Cancer With Recombinant Methioninase, Rapamycin and Chloroquine Is Specific and Synergistic to MiaPaCa-2 Pancreatic-Cancer Cells in Contrast to Hs-27 Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Cancers|November 27, 2025
Factors Associated with Bone Union Failure After Frozen Autograft Reconstruction in Lower Limb OsteosarcomaSei Morinaga, Katsuhiro Hayashi, Shinji Miwa, et al.
Anticancer Research|June 26, 2024
Membrane Formed Around Liquid Nitrogen-treated Bone Promotes Osteogenesis and Revitalization in a Rat ModelYohei Asano, Norio Yamamoto, Katsuhiro Hayashi, et al.
Cancer Diagnosis & Prognosis|July 2, 2026
Pediatric Distal Femoral Surface Tumor With Extraosseous Lesion Mimicking Parosteal Osteosarcoma: A Diagnostic ChallengeRio Wikanjaya, Sei Morinaga, Katsuhiro Hayashi, et al.
Anticancer Research|June 27, 2025
The Conditions of Non-rescuability of Methioninase-treated Cancer Cells by Methionine Replenishment: The Point of No ReturnByung Mo Kang, Qinghong Han, Shukuan Li, et al.
The Journal of Hand Surgery Asian-Pacific Volume|April 22, 2020
Timing of Surgery for Pediatric Supracondylar Humerus Fractures and Early Postoperative ResultsSeigo Suganuma, Kaoru Tada, Hidetoshi Yasutake, et al.
Cancer Diagnosis & Prognosis|May 4, 2026
The Combination of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 and Recombinant Methioninase Is Not Cancer-selective in a Co-culture Model of Colon Cancer Cells and Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Journal of Medical Case Reports|November 16, 2022
Insufficiency fracture of the supra-acetabulum that required differentiation from a pathological fracture secondary to a malignant bone tumor: a case reportSei Morinaga, Norio Yamamoto, Katsuhiro Hayashi, et al.
Anticancer Research|November 29, 2025
The Combination of Recombinant Methioninase and Low-dose Chloroquine Selectively Eradicates Colon-Cancer Cells Without Apparent Toxicity on Co-cultured Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research|December 30, 2025
Effect of Recombinant Methioninase Dose and Timing on the Selective and Precise Elimination of Cancer Cells from Co-Cultured Normal Cells and on Methionine-dependent Rescue of Cancer CellsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research|October 28, 2025
Simultaneous Targeting of Multiple Hallmarks of Cancer With Recombinant Methioninase, Rapamycin and Chloroquine Is Specific and Synergistic to MiaPaCa-2 Pancreatic-Cancer Cells in Contrast to Hs-27 Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Pageof 9